Stason Pharmaceuticals, Inc
Close-out letter issued July 8, 2020 · Irvine, California
- Inspection
- Oct 3 – Oct 25, 2019
- Pages
- 6
- FEI number
- 1000160561
In short: On July 8, 2020, FDA sent Stason Pharmaceuticals, Inc in Irvine, California (FEI 1000160561) a close-out letter, confirming that the issues in an earlier warning letter were addressed.
Inside this close-out letter
The full close-out letter
Every page of the close-out letter, exactly as written.
Get the full close-out letterThis inspection in context
Questions about this close-out letter
When was Stason Pharmaceuticals, Inc inspected by FDA?
The inspection ran Oct 3 – Oct 25, 2019, and the Close-out letter is dated July 8, 2020.
How do I get the full Close-out letter for Stason Pharmaceuticals, Inc?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.